All News #Library
Others
GV20 Therapeutics Presents GV20-0251 Translational Findings
18 Mar 2026 //
PR NEWSWIRE
GV20 Therapeutics Hits ADC Milestone with Mitsubishi Tanabe
25 Nov 2025 //
PR NEWSWIRE
GV20 Therapeutics Reports Phase 1 Data On GV20-0251 At ESMO
16 Sep 2024 //
PR NEWSWIRE
GV20 Therapeutics To Present GV20-0251 Clinical Data At ESMO 2024
21 Aug 2024 //
PR NEWSWIRE

Market Place
Sourcing Support